B-Cell Chronic Lymphocytic Leukemia Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: B4B00ACDEE94EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of B-Cell Chronic Lymphocytic Leukemia Treatment in Global, including the following market information:

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

AMG-319 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of B-Cell Chronic Lymphocytic Leukemia Treatment include AB Science SA, Amgen Inc., Celgene Corporation, Dynavax Technologies Corporation, Eisai, Elsalys Biotech SAS, F. Hoffmann-La Roche Ltd., iDD biotech SAS and Immunomedics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the B-Cell Chronic Lymphocytic Leukemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, by Type, 2021 (%)

• AMG-319
• ATTCK-20
• IDD-002
• JNJ-64052781
• Lenalidomide
• MAT-303
• MT-3724
• Others

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies B-Cell Chronic Lymphocytic Leukemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies B-Cell Chronic Lymphocytic Leukemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AB Science SA
• Amgen Inc.
• Celgene Corporation
• Dynavax Technologies Corporation
• Eisai
• Elsalys Biotech SAS
• F. Hoffmann-La Roche Ltd.
• iDD biotech SAS
• Immunomedics, Inc.
• Johnson & Johnson
• Juno Therapeutics Inc.
• Molecular Templates Inc.
• Noxxon Pharma AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size: 2021 VS 2028
2.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market
3.2 Top Global B-Cell Chronic Lymphocytic Leukemia Treatment Companies Ranked by Revenue
3.3 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 B-Cell Chronic Lymphocytic Leukemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 B-Cell Chronic Lymphocytic Leukemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 AMG-319
  4.1.3 ATTCK-20
  4.1.4 IDD-002
  4.1.5 JNJ-64052781
  4.1.6 Lenalidomide
  4.1.7 MAT-303
  4.1.8 MT-3724
  4.1.9 Others
4.2 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
  4.2.1 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028
  6.3.2 US B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.3.3 Canada B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.3.4 Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028
  6.4.2 Germany B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.3 France B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.4 U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.5 Italy B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.6 Russia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.4.8 Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028
  6.5.2 China B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.5.3 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.5.4 South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.5.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028
  6.6.2 Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.6.3 Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028
  6.7.2 Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.7.3 Israel B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028
  6.7.5 UAE B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AB Science SA
  7.1.1 AB Science SA Corporate Summary
  7.1.2 AB Science SA Business Overview
  7.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.1.4 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 AB Science SA Key News
7.2 Amgen Inc.
  7.2.1 Amgen Inc. Corporate Summary
  7.2.2 Amgen Inc. Business Overview
  7.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.2.4 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Amgen Inc. Key News
7.3 Celgene Corporation
  7.3.1 Celgene Corporation Corporate Summary
  7.3.2 Celgene Corporation Business Overview
  7.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.3.4 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Celgene Corporation Key News
7.4 Dynavax Technologies Corporation
  7.4.1 Dynavax Technologies Corporation Corporate Summary
  7.4.2 Dynavax Technologies Corporation Business Overview
  7.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.4.4 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Dynavax Technologies Corporation Key News
7.5 Eisai
  7.5.1 Eisai Corporate Summary
  7.5.2 Eisai Business Overview
  7.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.5.4 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Eisai Key News
7.6 Elsalys Biotech SAS
  7.6.1 Elsalys Biotech SAS Corporate Summary
  7.6.2 Elsalys Biotech SAS Business Overview
  7.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.6.4 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Elsalys Biotech SAS Key News
7.7 F. Hoffmann-La Roche Ltd.
  7.7.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.7.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.7.4 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.7.5 F. Hoffmann-La Roche Ltd. Key News
7.8 iDD biotech SAS
  7.8.1 iDD biotech SAS Corporate Summary
  7.8.2 iDD biotech SAS Business Overview
  7.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.8.4 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.8.5 iDD biotech SAS Key News
7.9 Immunomedics, Inc.
  7.9.1 Immunomedics, Inc. Corporate Summary
  7.9.2 Immunomedics, Inc. Business Overview
  7.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.9.4 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.9.5 Immunomedics, Inc. Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.10.4 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News
7.11 Juno Therapeutics Inc.
  7.11.1 Juno Therapeutics Inc. Corporate Summary
  7.11.2 Juno Therapeutics Inc. Business Overview
  7.11.3 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.11.4 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.11.5 Juno Therapeutics Inc. Key News
7.12 Molecular Templates Inc.
  7.12.1 Molecular Templates Inc. Corporate Summary
  7.12.2 Molecular Templates Inc. Business Overview
  7.12.3 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.12.4 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.12.5 Molecular Templates Inc. Key News
7.13 Noxxon Pharma AG
  7.13.1 Noxxon Pharma AG Corporate Summary
  7.13.2 Noxxon Pharma AG Business Overview
  7.13.3 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Major Product Offerings
  7.13.4 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global Market (2017-2022)
  7.13.5 Noxxon Pharma AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. B-Cell Chronic Lymphocytic Leukemia Treatment Market Opportunities & Trends in Global Market
Table 2. B-Cell Chronic Lymphocytic Leukemia Treatment Market Drivers in Global Market
Table 3. B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints in Global Market
Table 4. Key Players of B-Cell Chronic Lymphocytic Leukemia Treatment in Global Market
Table 5. Top B-Cell Chronic Lymphocytic Leukemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies B-Cell Chronic Lymphocytic Leukemia Treatment Product Type
Table 9. List of Global Tier 1 B-Cell Chronic Lymphocytic Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B-Cell Chronic Lymphocytic Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AB Science SA Corporate Summary
Table 31. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 32. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Inc. Corporate Summary
Table 34. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 35. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Celgene Corporation Corporate Summary
Table 37. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 38. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Dynavax Technologies Corporation Corporate Summary
Table 40. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 41. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Eisai Corporate Summary
Table 43. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 44. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Elsalys Biotech SAS Corporate Summary
Table 46. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 47. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 49. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 50. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 51. iDD biotech SAS Corporate Summary
Table 52. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 53. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Immunomedics, Inc. Corporate Summary
Table 55. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 56. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 59. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Juno Therapeutics Inc. Corporate Summary
Table 61. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 62. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Molecular Templates Inc. Corporate Summary
Table 64. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 65. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Noxxon Pharma AG Corporate Summary
Table 67. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product Offerings
Table 68. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type in 2021
Figure 2. B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Application in 2021
Figure 3. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2021
Figure 8. By Type - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 12. US B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 24. China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE B-Cell Chronic Lymphocytic Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)